Minerva Neurosciences (NERV) Cash from Financing Activities (2013 - 2026)
Minerva Neurosciences (NERV) posted Cash from Financing Activities of $1.1 million for Q1 2026, down 98.55% on a QoQ basis from $74.5 million in Q4 2025.
Minerva Neurosciences (NERV) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Minerva Neurosciences' Cash from Financing Activities history runs 12 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.5 million (changed N/A YoY) and the FY2025 annual result came in at $74.5 million, changed N/A from the prior year.
- Cash from Financing Activities was $1.1 million for Q1 2026 at Minerva Neurosciences, down from $74.5 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $74.5 million in Q4 2025 and bottomed at -$86691.0 in Q3 2023.
- A 3-year average of $19.0 million and a median of $1.1 million in 2026 frame the typical range for Cash from Financing Activities.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 74.50 Mn |
| Dec 31, 2025 | 74.50 Mn |
| Sep 30, 2025 | -45,166.00 |
| Sep 30, 2025 | -45,166.00 |
| Sep 30, 2023 | -86,691.00 |
| Sep 30, 2023 | -86,691.00 |
| Jun 30, 2023 | 19.69 Mn |
| Jun 30, 2023 | 19.69 Mn |
| Mar 31, 2021 | 60.00 Mn |
| Mar 31, 2021 | 60.00 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Mar 31, 2020 | 797,629.00 |
| Mar 31, 2020 | 797,629.00 |
| Dec 31, 2019 | -1.00 |
| Dec 31, 2019 | -1.00 |